Background
The monthly disbursement of social assistance (SA) payments to people
who use illicit drugs (PWUD) has been temporally associated with increases
in drug-related harm. Yet, whether SA receipt changes drug use intensity
compared to levels of use at other times in the month has not been
established. We therefore examined this relationship among PWUD in
Vancouver, Canada (2005–2013).
Methods
Data were derived from prospective cohorts of HIV-positive and
HIV-negative PWUD. Every six months, participants were asked about their
illicit drug use during the last 180 days and the past week. We determined
whether SA receipt occurred within the assessment’s one-week recall
period. We employed generalized estimating equations controlling for
confounders to examine the relationship between SA receipt and the change in
drug use intensity, defined as a 100% increase in the average times
per day a given drug was used in the last week compared to the previous 6
months. We tested the robustness of this relationship by stratifying
analyses by whether individuals primarily used stimulants, illicit opioids
or engaged in polydrug use and examining the timing of SA receipt relative
to date of assessment.
Results
Our study included 2,661 individuals (median age 36, 32%
female) with 1,415 (53.2%) reporting SA receipt occurring within the
one-week recall period of the assessment at least once. SA receipt was
independently associated with intensified drug use (Adjusted Odds Ratio
[AOR]: 1.79; 95% Confidence Interval [CI]: 1.53, 2.09), and remained
significant when stratified by primary use of stimulants (AOR: 1.87;
95% CI: 1.54, 2.26), opioids (AOR: 1.96; 95% CI: 1.23, 3.13)
and polydrug use (AOR: 1.53; 95% CI: 1.11, 2.10).
Conclusion
We found a temporal association between SA receipt and drug use
intensification. While the health and social benefits of SA are significant,
these findings suggest that alternative disbursement strategies, such as
staggered or smaller and more frequent SA payments may be able to mitigate
drug-related harm. Alternatives should be tested rigorously.